Beruflich Dokumente
Kultur Dokumente
B Y
ENVIRONMENTAL FACTORS
- PEER GROUP
INDIVIDUAL FACTORS
- PERSONALITY
- FAMILY INTERACTION
TIME TO BRAIN
SMOKING 7 10 SECONDS INJECTING : - IV 15 30 SECONDS - IM 3 5 MINUTES 3. SNORTING 3 5 MINUTES 4. CONTACT : - EYE 3 5 MINUTES - SKIN & OTHER 15 30 MINUTES 5. INGESTING 20 30 MINUTES
PREVENTION OF RELAPSE
PSYCHOACTIVE SUBSTANCE DEPENDENCE
SPECIFIC TREATMENT
DRUG TREATMENT COUNSELING RESIDENTIAL REHABILITATION
INDIVIDUAL FACTORS
MOTIVATION SOCIAL SUPPORTS EXTENT OF PHYSICAL AND PSYCHOLOGICAL DAMAGE PAST EXPERIENCE OF TREATMENT PREPARED TO ATTEND SELFHELP GROUPS, VOLUNTARY ORGANIZATION
8.
9.
Pelajar
Pengangguran J U M LAH :
35
333 1308
105
848
206
141
145
632
6184 18769
Thn Jml 12 6
Thn Jml 21 10
Thn Jml 36 37
Thn Jml 39 6
Thn Jml 29 33
3.
4. 5. 6. 7. 8. 9.
SWASTA
WRSWT PETANI BURUH MHSW PELAJAR
PENGANG GURAN
357
265 90 149 61 35 333
1308
27,29
20,26 6,88 11,39 4,66 2,68 25,46 100
698
423 95 263 127 105 848
2590
26,95
16,33 3,67 10,15 4,90 4,05 32,74 100
1268
669 154 569 260 206 1756 4955
25,59
13,50 3,11 11,48 5,25 4,16 35,44 100
1228
769 127 833 202 141 1579 4924
24,94
15,62 2,58 16,92 4,10 2,86 32,07 100
1639
619 91 554 241 145 1668 5019
32,66
12,33 1,81 11,04 4,80 2,89 33,23 100
JML
ALCOHOL-RELATED DISORDERS
1. 2. 3. 4. IN ALCOHOL DEPENDENCE, DENIAL AND MINIMIZATION ARE COMMON. WITHDRAWAL AND DELIRIUM TREMENS ARE TREATED WITH BENZODIAZEPINES. PEAK INCIDENCE OF ALCOHOLIC SEIZURES IS WITHIN 24 TO 48 HOURS. REHABILITATION IS AIMED AT ABSTINENCE AND TREATING COMORBID DISORDERS. REHABILITATION INVOLVES AA AND GROUP AND FAMILY THERAPIES. FIFTY PERCENT OF TREATED ALCOHOLICS WILL RELAPSE. WERNICKE-KORSAKOFF SYNDROME IS DUE TO THIAMINE DEFICIENCY. WERNICKES TRIAD CONSISTS OF NYSTAGMUS, ATAXIA, AND MENTAL CONFUSION. KORSAKOFFS SYMPTOMS ARE ANTEROGRADE AMNESIA AND CONFABULATION.
5.
6. 7. 8. 9.
HOSPITALIZATION
IS INDICATED FOR PATIENT WHO:
ARE AT RISK FOR DANGEROUS OR UNCOMFORTABLE WITHDRAWAL SYNDROMES (ALCOHOL, SEDATIVEHYPNOTICS, OPIOIDS). HAVE MEDICAL COMPLICATION FROM INTOXICATION OR WITHDRAWAL (SUCH AS COCAINE-INDUCED ISCHEMIA OR ALCOHOL WITHDRAWAL SEIZURES). HAVE PERSISTING SUBSTANCE- INDUCED PSYCHOTIC SYMPTOMS AND CANNOT BE DISCHARGED TO AN ADEQUATELY SUPERVISED OUTPATIENT ENVIRONMENT. ARE AT RISK FOR COMPLETED SUICIDE SECONDARY TO COMORBID PSYCHOSOCIAL CONDITIONS THAT ARE COMPLICATED BY SUBSTANCE USE.
1. 2. 3. 4.
5.
A NUMBER AT DIFFERENT APPROACH ARE AVAILABLE, AND PACKAGES OF CARE SHOULD BE DESIGNED TO MEET INDIVIDUAL NEEDS. TREATMENT OPTIONS INCLUDE THE FOLLOWING : HARM REDUCTION PSYCHOTHERAPY RESIDENTIAL REHABILITATION MEDICAL DETOXIFICATION : i.e. - METHADONE FOR OPIATE WITHDRAWAL - BENZODIAZEPINE FOR ALCOHOL WITHDRAWAL - SYMPTOMATIC COLD TURKEY
TWELVE-STEP PROGRAM
STEP 1 : ADMITTED WE WERE POWERLESS OVER ALCOHOL-THAT OUR LIVES HAD BECOME UNMANAGEABLE. STEP 2 : COME TO BELIEVE THAT A POWER GREATER THAN OURSELVES COULD RESTORE US TO SANITY. STEP 3 : MADE A DECISION TO TURN OUR WILL AND OUR LIVES OVER TO THE CASE OF GOD AS WE UNDERSTOOD HIM. STEP 4 : MADE A SEARCHING AND FEARLESS MORAL INVENTORY OF OURSELVES. STEP 5 : ADMITTED TO GOD, TO OURSELVES, AND TO ANOTHER HUMAN BEING THE EXACT NATURE OF OUR WRONGS. STEP 6 : WERE ENTIRELY READY TO HAVE GOD REMOVE ALL THESE DEFECTS OF CHARACTER. STEP 7 : HUMBLY ASKED HIM TO REMOVE OUR SHORTCOMINGS.
TWELVE-STEP PROGRAM
STEP 8 : MADE A LIST OF ALL PERSONS WE HAD HARMED, AND BECAME WILLING TO MAKE AMENDS TO THEM ALL. STEP 9 : MADE DIRECT AMENDS TO SUCH PEOPLE WHEREVER IMPOSSIBLE, EXCEPT WHEN TO DO SO WOULD INJURE THEM ALL. STEP 10 : CONTINUED TO TAKE PERSONAL INVENTORY AND WHEN WE WERE WRONG PROMPTLY ADMITTED IT. STEP 11 : SOUGHT THROUGH PRAYER AND MEDITATION TO IMPROVE OUR CONSCIOUS CONTACT WITH GOD AS WE UNDERSTOOD HIM, PRAYING ONLY FOR KNOWLEDGE OF HIS WILL FOR US AND THE POWER TO CARRY THAT OUT. STEP 12 : HAVING HAD A SPIRITUAL AWAKENING AS THE RESULT OF THESE STEPS, WE TRIED TO CARRY THIS MESSAGE TO ALCOHOLICS, AND TO PRACTICE THESE PRINCIPLES IN ALL OUR AFFAIRS.
SUBSTANCE ABUSE
THE DSM-IV DEFINES SUBSTANCE ABUSE AS A MALADAPTIVE PATTERN OF SUBSTANCE USE LEADING TO CLINICALLY SIGNIFICANT IMPAIRMENT OR DISTRESS AS MANIFEST BY FAILURE TO FULFILL MAJOR ROLE OBLIGATIONS AT HOME, SCHOOL, OR WORK; RECURRENT SUBSTANCE USE IN SITUATIONS IN WHICH IT IS PHYSICALLY HAZARDOUS; RECURRENT SUBSTANCE-RELATED LEGAL PROBLEMS; RECURRENT SUBSTANCE USE DESPITE PERSISTENT OR RECURRENT SOCIAL OR INTERPERSONAL PROBLEMS CAUSED OR EXACERBATED BY THE EFFECTS OF THE SUBSTANCE.
SUBSTANCE DEPENDENCE
SUBSTANCE DEPENDENCE IS DEFINED AS A MALADAPTIVE PATTERN OF SUBSTANCE USE LEADING TO CLINICALLY SIGNIFICANT IMPAIRMENT OR DISTRESS, AS MANIFESTED BY THREE (OR MORE) OF THE FOLLOWING : 1. TOLERANCE 2. WITHDRAWAL 3. REPEATED, UNINTENDED, EXCESSIVE USE 4. PERSISTENT FAILED EFFORT TO CUT DOWN 5. EXCESSIVE TIME SPENT TRYING TO OBTAIN THE SUBSTANCE 6. REDUCTION IN IMPORTANT SOCIAL, OCCUPATIONAL, OR RECREATIONAL ACTIVITIES 7. CONTINUED USE DESPITE AWARENESS THAT SUBSTANCE IS THE CAUSE OF PSYCHOLOGICAL OR PHYSICAL DIFFICULTIES.
(a) (b)
(c)
(d) (e)
(f)
DYSARTHRIA ATAXIA IMPAIRED ATTENTION OR MEMORY AMNESIA (BLACKOUTS) NYSTAGMUS STUPOR OR COMA AFFECTIVE LABILITY DELIRIUM OR HALLUCINOSIS MAY BE PRESENT
INTERRUPT USE MONITOR VITAL SIGNS HOURLY FOR SYMPTOMS OF WITHDRAWAL. GASTRIC LAVAGE WITH ACTIVATED CHARCOAL MAY BE USEFUL. SUPPORT RESPIRATION IF INTOXICATION IS SEVERE. IV FLUID REPLACEMENT MAY BE NECESSARY IF THE PATIENT HAS BEEN VOMITING OR IS OTHERWISE UNABLE TO TAKE PO FLUIDS. PLACE PATIENT IN A QUIET, CONTROLLED ENVIRONMENT WITH REDUCED SENSORY STIMULATION. LOW-DOSE, HIGH-POTENCY ANTIPSYCHOTICS MAY BE USED TO CONTROL SUBSTANCE-INDUCED PSYCHOSIS. GIVE THIAMINE, 100-200 mg IV, BEFORE GLUCOSE ADMINISTRATION (ALCOHOL USE).
3. 4. 5.
RECREATION USE OF OPIATES OFTEN LEADS TO ADDICTION. OPIATE ADDICTS ARE AT INCREASED RISK OF HIV, PNEUMONIA, ENDOCARDITIS, HEPATITIS, AND CELLULITIS. HIGH MORTALITY OCCURS FROM ACCIDENTAL OVERDOSE, SUICIDE, AND ACCIDENTS. OPIATE WITHDRAWAL BEGINS 10 HOURS AFTER LAST DOSE. WITHDRAWAL IS UNCOMFORTABLE BUT NOT USUALLY MEDICALLY COMPLICATED.
OPIOIDS
CLINICAL FEATURES OF INTOXICATION
EUPHORIA SEDATION OR SLEEPINES (NODDING) RESPIRATORY DEPRESSION PUPILLARY CONSTRICTION (PINPOINT PUPILS) DYSARTHRIA PERCEPTUAL DISTURBANCES IMPAIRMENT OF MEMORY OR ATTENTION NAUSEA CONSTIPATION WITH DECREASED BOWEL SOUNDS REDUCED SEXUAL DESIRE DELIRIUM MAY OCCUR WITH INTOXICATION
OPIOIDS
CLINICAL FEATURES OF WITHDRAWAL
USUALLY DEVELOPS WITHIN HOURS OF CESSATION OF IV USAGE, OR 1-2 DAYS AFTER CESSATION OF ORAL USAGE ANXIETY, IRRITABILITY INSOMNIA MYALGIA OR MUSCLE CRAMPING HEADACHE NAUSEA/VOMITING DIARRHEA OR ABDOMINAL CRAMPING PILOERECTION (GOOSE FLESH) DIAPHORESIS PUPILLARY DILATION LACRIMATION RHINORRHEA YAWNING FEVER
TREAT PSYCHIATRIC COMORBIDITIES ( e.g., MAJOR DEPRESSION, ANXIETY DISORDERS). TWELVE-STEP RECOVERY MODELS REPRESENT THE MOST SUCCESSFUL BEHAVIORAL APPROACH TO ABSTINENCE. NALTREXONE (ReVia), 50 mg PO qd, BLOCKS THE REWARDING EFFECTS OF OPIOIDS.. METHADONE, 60-100 mg PO qd, REDUCES DRUG CRAVING AND ALLEVIATES SOME OF THE PSYCHOSOCIAL CONSEQUENCES AND MEDICAL COMORBIDITIES OF ILLEGAL DRUG USE. LAAM (LEVO-ALPHA-ACETYLMETHADOL) IS A LONG-ACTING OPIATE AGONIST (HALF-LIFE OF 92 HRS) THAT CAN BE USED SIMILARLY TO METHADONE, WITH THE ADVANTAGE THAT IT CAN BE DOSED EVERY 2-3 DAYS. BOTH METHADONE AND LAAM MAINTENANCE THERAPY CAN ONLY BE PRESCRIBERD THROUGH GOVERNMENT-REGULATED PROGRAMS.
CANNABIS
CLINICAL FEATURES OF INTOXICATION
EUPHORIA DEPERSONALIZATION DEREALIZATION SENSATION OF SLOWED TIME IMPAIRED COORDINATION SILLY OR INAPPROPRIATE AFFECT OR LAUGHING AMOTIVATION CONJUNCTIVAL INJECTION INCREASED APPETITE DRY MOUTH TACHYCARDIA PERCEPTUAL DISTURBANCES PSYCHOSIS, INCLUDING AUDITORY AND VISUAL HALLUCINATIONS AND PARANOID DELUSIONS (USUALLY THAT PEOPLE ARE WATCHING THEM OR ARE AWARE OF THEIR USE). DELIRIUM MAY OCCUR WITH INTOXICATION.
CANNABIS
CLINICAL FEATURES OF WITHDRAWAL
NOTE : NO DSM CATEGORY
INSOMNIA NAUSEA IRRITABILITY AND RESTLESSNESS YAWNING CHILLS DIARRHEA INFREQUENT OCCURRENCE, ONLY IN CHRONIC USERS OF LARGE AMOUNTS.
SYMPTOMS ARE SELFLIMITED AND MILD, AND NO PHARMACOLOGIC MANAGEMENT HAS BEEN DEMONSTRATED TO BE USEFUL.
PHENCYCLIDINE
CLINICAL FEATURES OF INTOXICATION
HYPERTENSION TACHYCARDIA ANALGESIA VERTICAL, HORIZONTAL OR ROTATORY NYSTAGMUS ATAXIA DYSARTHRIA HYPERTONIA SEIZURE AND COMA HYPERSALIVATION DIAPHORESIS FEVER AUDITORY HALLUCINATIONS AND DELUSIONS AFFECT MAY BE LABILE OR BLUNTED DISSOCIATION AND INATTENTION ODD POSTURING OR REPETITIVE MOVEMENTS CATATONIA DELIRIUM MAY OCCUR WITH INTOXICATION.
HALLUCINOGENS
CLINICAL FEATURES OF INTOXICATION
TREMOR BLURRED VISION INCOORDINATION GI SYMPTOMS, INCLUDING N/V, CRAMPING, FLATULENCE, AND DIARRHEA, ARE COMMON WITH MESCALINE AND MUSHROOM. MDMA INTOXICATION IS MORE LIKELY TO CAUSE HEIGHTENED SOCIABILITY, WITH INCREASED SPEECH, TACTILE PREOCCUPATION, AND HYPERSEXUALITY. BECAUSE OF THE CONTEXT IN WHICH MDMA IS USED, IT IS MORE LIKELY TO BE ASSOCIATED WITH THE PHYSIOLOGY SEQUELAE OF AUTONOMIC HYPERACTIVITY (e.g.,DEHYDRATION, CARDIOVASCULAR CRISIS).
HALLUCINOGENS
CLINICAL FEATURES OF INTOXICATION
VISUAL AND AUDITORY ILLUSIONS AND HALLUCINATIONS. SYNESTHESIA: THE EXPERIENCE OF PERCEIVING SENSORY INPUT FROM ONE MODALITY IN ANOTHER MODALITY (e.g.,HEARING COLOR OR SEEING SOUNDS). SUBJECTIVE HEIGHTENED AWARENESS OF SENSORY INPUT. FEELING OF DEPERSONALIZATION OR DEREALIZATION. IDEAS OF REFERENCE. PARANOIA OR FEAR OF LOSING ONES MIND. ANXIETY OR AFFECTIVE LABILITY. AUTONOMIC ACTIVATION (PUPILLARY DILATATION, TACHYCARDIA, SWEATING, HYPERTENSION, FEVER).
INHALANTS
CLINICAL FEATURES OF INTOXICATION
EUPHORIA DISORIENTATION MEMORY IMPAIRMENT DIZZINESS CONFUSION HEADACHE DIPLOPIA DYSARTHRIA, ATAXIA, NYSTAGMUS HYPOTENSION, BRADYCARDIA, ARRHYTHMIA. INJECTED SCLERA LACRIMATION SALIVATION RHINORRHEA RESPIRATORY WHEEZING SEIZURES OR COMA NAUSEA/VOMITING HEPATOXICITY CHEMICAL PNEUMONITIS THE ODOR OF SOLVENTS DETECTED ON BREATH AND CLOTHING